Vir Biotechnology Inc (NASDAQ:VIR) has a beta value of 0.43 and has seen 0.92 million shares traded in the last trading session. The company, currently valued at $1.44B, closed the last trade at $10.68 per share which meant it lost -$0.08 on the day or -0.74% during that session. The VIR stock price is -157.3% off its 52-week high price of $27.48 and 27.72% above the 52-week low of $7.72. The 3-month trading volume is 1.11 million shares.
Vir Biotechnology Inc (NASDAQ:VIR) trade information
Sporting -0.74% in the red in last session, the stock has traded in the red over the last five days, when the VIR stock price touched $10.68 or saw a rise of 7.21%. Year-to-date, Vir Biotechnology Inc shares have moved 6.16%, while the 5-day performance has seen it change -6.32%. Over the past 30 days, the shares of Vir Biotechnology Inc (NASDAQ:VIR) have changed 3.59%.
Vir Biotechnology Inc (VIR) estimates and forecasts
Figures show that Vir Biotechnology Inc shares have underperformed across the wider relevant industry. The company’s shares have gained 8.76% over the past 6 months, with this year growth rate of 11.98%, compared to 13.60% for the industry. Other than that, the company has, however, increased its growth outlook for the 2024 fiscal year revenue. Growth estimates for the current quarter are 0.90% and 29.00% for the next quarter. Revenue growth from the last financial year stood is estimated to be -52.00%.
6 analysts offering their estimates for the company have set an average revenue estimate of $11.99 million for the current quarter. 6 have an estimated revenue figure of $9.35 million for the next quarter concluding in Jun 2024. Year-ago sales stood $50.1 million and $3.8 million respectively for this quarter and the next, and analysts expect sales will shrink by -76.10% for the current quarter and 146.20% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -34.12% over the past 5 years. Earnings growth for 2024 is a modest 10.92% while over the next 5 years, the company’s earnings are expected to increase by 7.00%.
VIR Dividends
Vir Biotechnology Inc is expected to release its next earnings report between May 02 and May 06 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Vir Biotechnology Inc (NASDAQ:VIR)’s Major holders
Insiders own 14.29% of the company shares, while shares held by institutions stand at 76.30% with a share float percentage of 89.02%. Investors are also buoyed by the number of investors in a company, with Vir Biotechnology Inc having a total of 303 institutions that hold shares in the company. The top two institutional holders are SB Investment Advisers (UK) LTD with over 16.68 million shares worth more than $409.26 million. As of Jun 29, 2023, SB Investment Advisers (UK) LTD held 12.43% of shares outstanding.
The other major institutional holder is Blackrock Inc., with the holding of over 13.97 million shares as of Jun 29, 2023. The firm’s total holdings are worth over $342.81 million and represent 10.41% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are iShares Core S&P Smallcap ETF and Vanguard Total Stock Market Index Fund. As of Sep 29, 2023, the former fund manager holds about 4.32% shares in the company for having 5.8 million shares of worth $54.36 million while later fund manager owns 3.12 million shares of worth $76.59 million as of Jun 29, 2023, which makes it owner of about 2.33% of company’s outstanding stock.
